SCHEMBL3069140

SCHEMBL3069140

N=C(N)NCCCCCNC(=N)N

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.67
MEN1 O00255 1/20 0.67
CYP1A2 P05177 1/20 0.67
KMT2A Q03164 1/20 0.67
ALOX15 P16050 1/20 0.54
HIF1A Q16665 2/20 0.40
ALB P02768 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SPHK1 Q9NYA1 3/20 0.37
PAOX Q6QHF9 2/20 0.37
PRSS1 P07477 4/20 0.37
F2 P00734 2/20 0.37
PRSS2 P07478 2/20 0.37
PRSS3 P35030 2/20 0.37
TMPRSS6 Q8IU80 2/20 0.37
ST14 Q9Y5Y6 2/20 0.37
ALDH1A2 O94788 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Synthalin SCHEMBL336302 1.00 SMN1; SMN2 (0.67) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
SCHEMBL434733 1.00 SMN1; SMN2 (0.67) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
SCHEMBL1923256 1.00 SMN1; SMN2 (0.67) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
SCHEMBL11882788 1.00 SMN1; SMN2 (0.67) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
SCHEMBL3072659 1.00 SMN1; SMN2 (0.67) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
SCHEMBL10728151 1.00 SMN1; SMN2 (0.67) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
Hydrochloric Acid SCHEMBL7146690 0.97 SMN1; SMN2 (0.64) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
Hydrochloric Acid SCHEMBL21715464 0.97 SMN1; SMN2 (0.64) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
Hydrochloric Acid SCHEMBL19994028 0.97 SMN1; SMN2 (0.64) SMN1; SMN2MEN1CYP1A2KMT2AALOX15
Synthalin SCHEMBL27953128 0.97 SMN1; SMN2 (0.64) SMN1; SMN2MEN1CYP1A2KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117297981-A Antibacterial dental repair material 北京化工大学 2023-12-29 CN claimed
EP-2196091-B1 Synergistic combinations comprising at least one fungicide and a guanidine salt STRAETMANS HIGH TAC GMBH (DE) 2010-12-08 EP claimed
EP-1447460-B1 Rust prevention coating agent and method of rust-proofing NIPPON PAINT CO LTD (JP) 2006-05-24 EP claimed
US-7029522-B2 Rust prevention coating agent and method of rust-proofing NIPPON PAINT CO., LTD. (JP) 2006-04-18 US claimed
US-20040217328-A1 Rust prevention coating agent and method of rust-proofing NIPPON PAINT CO., LTD (JP) 2004-11-04 US claimed
EP-1447460-A1 Rust prevention coating agent and method of rust-proofing Nippon Paint Co., Ltd. (JP) 2004-08-18 EP claimed
CN-117297981-A Antibacterial dental repair material 北京化工大学 2023-12-29 CN disclosed
EP-2376074-B1 METHOD FOR IMPROVED BIOACTIVATION OF MEDICATIONS DRITTE PATENTPORTFOLIO BETEILI (DE) 2019-03-13 EP disclosed
US-20120077876-A1 Method For Improved Bioactivation Of Pharmaceuticals DRITTE PATENTPORTFOLIO BETEILIGUNGSGESELLSCHAFT MBH & CO. KG (DE) 2012-03-29 US disclosed
US-20120077876-A1 Method For Improved Bioactivation Of Pharmaceuticals DRITTE PATENTPORTFOLIO BETEILIGUNGSGESELLSCHAFT MBH & CO. KG (DE) 2012-03-29 US disclosed
US-7833331-B2 Non-toxic corrosion-protection pigments based on cobalt UNIVERSITY OF DAYTON (US) 2010-11-16 US disclosed
US-7789917-B2 Amphoteric stilbene composition HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2010-09-07 US disclosed
US-7789958-B2 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON (US) 2010-09-07 US disclosed
WO-2004009869-A2 CORROSION-INHIBITING COATING FOR METAL SURFACES UNIVERSITY OF DAYTON (US) 2004-01-29 WO disclosed
US-20040011252-A1 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON 2004-01-22 US disclosed
US-20030234063-A1 Non-toxic corrosion-protection conversion coats based on cobalt DAYTON, UNIVERSITY OF 2003-12-25 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003060191-A2 NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077876-A1 Method For Improved Bioactivation Of Pharmaceuticals CYP2B6, CYP1A2, CYP2D6 SMN1; SMN2 2764/4885MEN1 2186/4885CYP1A2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.